New pulsed field ablation device aims to tame stubborn heart rhythm disorder
NCT ID NCT07281521
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device that uses pulsed electric fields to treat persistent atrial fibrillation, a type of irregular heartbeat. Researchers will enroll 200 people to see if the procedure is safe and can restore normal heart rhythm. The goal is to offer a more precise and less risky alternative to standard treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pulsed field ablation device
What this could lead to
If successful, this could offer a safer, more effective way to treat persistent atrial fibrillation and reduce the need for lifelong medication.
What could go wrong
This is an early-stage device trial with 200 participants. Risks include serious complications like stroke or heart damage, and long-term success is not yet proven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Homolka
NOT_YET_RECRUITINGPrague, Czechia
-
KBC Split
RECRUITINGSplit, Croatia
-
St. Anne's University Hospital
NOT_YET_RECRUITINGBrno, Czechia